ZS Associates

Digital

Recursion, Exscientia, and AI drug discovery’s moment of tru...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger.

Patients

Cell and gene therapies and the tricky question of patient s...

Cell and gene therapies represent the cutting edge of pharma technology, but how are patients experiencing this treatment revolution?

Market Access

The 2024 biopharma M&A landscape: An overview

It’s been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats.

R&D

Pharmaceutical research in space

When US President Joe Biden talks about his Cancer Moonshot, he's not literally talking about the moon - he's referencing the legendary innovation push that got Americans to the moon in 196

Digital

Reuters Pharma USA – Maria Whitman

At Reuters Pharma USA in March, ZS Associates' Maria Whitman sat down with pharmaphorum to discuss why it's time to reinvent pharma's marketing strategy

News

ZS mourns death of co-founder Andy Zoltners

The biopharma industry has lost another leading figure with the passing of Andy Zoltners, co-founder of ZS Associates, on the 40th anniversary of the company.